Luminal-type breast cancers, which make up approximately 70% of all breast cancers, are defined by the expression of and dependence upon the estrogen receptor (ER; ref. 2) and nearly 90% of primary prostate cancers are defined by expression and dependence on the androgen receptor (AR; ref. 3). Here, AR is linked to breast carcinoma.